GlassScriptPhysician profile
Chad M Boustany
NPI 1114182029
$9,580.14
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,387 · 2020: $329 · 2021: $7,034 · 2022: $69.66 · 2023: $465 · 2024: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397 · Gift: $256 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.60 |
| Gift | $256.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $107.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $7,686.22 | 2019-2021 | |
| Nobel Biocare USA | $726.12 | 2019-2023 | Nobelactive |
| Henry Schein, INC. | $266.28 | 2019 | |
| Straumann USA LLC | $250.25 | 2020-2024 | |
| Ultradent Products INC | $236.90 | 2022-2024 | Opalescence |
| Ivoclar Vivadent, INC. | $149.50 | 2020 | |
| Southern Implants North America INC | $100.80 | 2024 | |
| Voco America INC. | $60.00 | 2024 | Futurabond U, Grandio So, Admira Fusion X-Tra |
| Dentsply Sirona INC | $31.67 | 2020-2023 | Implant Dentistry |
| Zest Holdings, LLC | $26.04 | 2022 | |
| Zimvie INC. | $21.28 | 2024 | |
| Zimmer Biomet Holdings, INC. | $13.24 | 2021 | |
| Kerr Corporation | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Boustany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.